Monday, 9 July, 2018 - 15:57
Strong returns for AusCann investors
SPECIAL REPORT: AusCann has benefited from a wave of interest in medicinal cannabis for pain relief to be the BN30’s top performer in shareholder returns for the year to June 30.
![]() |
NEW ROLE: Marion Lesaffre, | 24 Nov 2020 |
![]() |
REMUNERATION UPDATE: Jonathan Cohen, Non-Executive Director | 13 Nov 2020 |
![]() |
REMUNERATION UPDATE: Pnina Feldman, Executive Chairman, Executive Director | 13 Nov 2020 |
![]() |
REMUNERATION UPDATE: David Austin, Non-Executive Director | 13 Nov 2020 |
![]() |
REMUNERATION UPDATE: Sholom Feldman, Chief Executive Officer, Executive Director, Managing Director | 13 Nov 2020 |
![]() |
NEW ROLE: Jonathan Cohen, Non-Executive Director | 03 Nov 2020 |
![]() |
NEW ROLE: Alexander Neuling, Company Secretary | 03 Nov 2020 |
![]() |
NEW ROLE: Pnina Feldman, Executive Chairman, Executive Director | 03 Nov 2020 |
![]() |
NEW ROLE: Sholom Feldman, Chief Executive Officer, Executive Director, Managing Director | 03 Nov 2020 |